-
Forward Look
Chemotherapy-free Treatment for Advanced Esophageal CancerPhysicians consider which patients are ideal for immunotherapy drug combinations.
by Leah Lawrence
-
Forward Look
Wrap-around Care for Kids With CancerLegislation creates opportunities and challenges for children with cancer who receive treatment while on hospice.
by Sharon Tregaskis
-
From the Editor-in-Chief
One-stop ShoppingTheranostics offers the promise of combining diagnosis and treatment.
by William G. Nelson, MD, PhD
-
Cervical Cancer Found at Later Stages After 65
A study found women in California were more likely to have cervical cancer diagnoses at a later stage after age 65.
by Jon Kelvey
-
Consider Immunotherapy Before Surgery for Melanoma
Immunotherapy before surgery is proving to be an effective treatment against melanoma.
by Sandra Gordon
-
Comparing Costs of At-Home Colorectal Screening Tests
Cologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.
by Jon Kelvey
-
A Personal Journey of Thyroid Cancer Treatment
The practical side of cancer treatment and life without a thyroid.
by Carly Flumer
-
Forward Look
Losing HeartCardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
by Marci A. Landsmann
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff